adopted various strategies to achieve the controlled differentiation of mesenchymal stem cells. Use of chemical cues such as dexamethasone, [2] l-ascorbic acid, [3] bone morphogenetic proteins, [4] and β-glycerol phosphate [5] are well-established practices in this regard. In recent years, understanding of mechanotransduction at the cellular and molecular level allows researchers to exploit various physical cues like flow-induced shear stress [6] and matrix stiffness [7] for osteogenic differentiation of hMSC. Another useful strategy in this regard is the application of electrical cues such as pulse-field and low-frequency electromagnetic field [8] on hMSC to induce osteogenic differentiation. Although the aforesaid strategies have found to be efficient, however, a biomimetic approach toward osteogenic differentiation of hMSC is being sought out over the years for tissue engineering. Use of implants [9] and scaffolds [10] with topographical, structural, and compositional characteristics similar to native bone has so far been the most recognized strategy for biomimetic differentiation of the hMSC. In principle, these approaches rely on the biomimicry of the extracellular components of the bone.In vivo, osteoblasts induce osteogenic differentiation of hMSC through paracrine and juxtacrine signaling. The major signaling pathways involved in these cellular processes are, extracellular regulated kinase (Erk)-activated MAPKinase and β1-Integrin signaling, [11] ephrin type B receptor 4 (EphB4)-ephrinB2 signaling [12,13] and Jagged1-mediated Notch signaling. [14,15] Since this cellular cross-talk involves the ligandreceptor interaction between osteoblasts and MSCs, therefore, from a mechanistic point of view, it is possible that a package derived from osteoblast containing the same set of ligands (both soluble and membrane-bound) can act in a similar manner and induces the osteogenic differentiation in hMSC. So far, this concept has been validated in cancer research where people have proved that microvesicles and exosomes released by cancer cells contain a significant amount of signaling molecules and those exosomes modulate the response of neighboring cells. [16] Recently, it has been shown that exosomes, derived from osteoblast are also capable of inducing osteogenic Exosome-mediated differentiation of human mesenchymal stem cell (hMSC) has opened up a new possibility for the directed osteogenic differentiation of hMSC by the osteoblast-derived vesicles. Here, it is hypothesized that giant plasma membrane vesicles (GPMVs) generated from osteoblast, can direct the osteogenic differentiation of hMSC. GPMVs having different membrane characteristics are generated from osteoblast cells (MG-63) using chemical vesiculants. It is deciphered that there is a treatment-dependent variation in the size and complexity in the GPMVs. It is also showed a variation in lipid composition among the GPMVs. It is demonstrated that GPMVs can be fused with hMSC in vitro and such fusion has no detrimental effect on the viability of hMSC. Furth...